CNTD2 抗体 (AA 30-110)
This anti-CNTD2 antibody is a 兔 多克隆 antibody detecting CNTD2 in ELISA 和 IHC (p). Suitable for 人.
Quick Overview for CNTD2 抗体 (AA 30-110) (ABIN7225112)
抗原
CNTD2
(Cyclin N-terminal Domain Containing 2 (CNTD2))
适用
人
宿主
兔
克隆类型
多克隆
标记
This CNTD2 antibody is un-conjugated
应用范围
ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
-
-
抗原表位
- AA 30-110
-
原理
- CNTD2 Polyclonal Antibody
-
特异性
- CNTD2 Polyclonal Antibody detects endogenous levels of CNTD2 protein.
-
纯化方法
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen
-
免疫原
- Synthesized peptide derived from the Internal region of human CNTD2 at AA range: 30-110
-
亚型
- IgG
-
-
anti-Cyclin N-terminal Domain Containing 2 (CNTD2) antibody
CNTD2 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC-P (1:100-1:300), ELISA (1:40000). Not yet tested in other applications.
-
说明
-
Primary Antibody
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
-
- CNTD2 (Cyclin N-terminal Domain Containing 2 (CNTD2))
-
别名
- CNTD2
-
背景
- Rabbit Anti-CNTD2 Polyclonal Antibody,CNTD2, Cyclin N-terminal domain-containing protein 2,CNTD2 (Cyclin N-Terminal Domain Containing 2) is a Protein Coding gene. Diseases associated with CNTD2 include cataract 27, nuclear progressive. GO annotations related to this gene include protein kinase binding.,Cyclin N-terminal domain-containing protein 2
-
基因ID
- 79935
-
UniProt
- Q9H8S5
抗原
-
You are here:
